Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

241 recalls, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 20262025202420232022 All years
Cause Sterility / contaminationNitrosamine impurityChemical / undeclaredParticulate / foreign matterLabeling / mix-upcGMP deviationMicrobial contamination All causes
Class II · Moderate risk

Proteus

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1135-2022
Class II · Moderate risk

Pertussinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1134-2022
Class II · Moderate risk

Morbillinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1133-2022
Class II · Moderate risk

Medorrhinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1132-2022
Class II · Moderate risk

Influenzinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1131-2022
Class II · Moderate risk

Diphtherinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1130-2022
Class II · Moderate risk

Colibacillinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1129-2022
Class II · Moderate risk

Anthracinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1125-2022
Class II · Moderate risk

Alcohol Antiseptic 80%

CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.

Ongoing cGMP deviation A.P. Nonweiler D-1142-2022
Class II · Moderate risk

Zonisamide Capsules

cGMP deviations

Completed cGMP deviation Glenmark Pharmaceuticals Inc., USA NDC 68462-130-01 D-0793-2022
Class II · Moderate risk

Zonisamide Capsules

cGMP deviations

Completed cGMP deviation Glenmark Pharmaceuticals Inc., USA NDC 68462-129-01 D-0792-2022
Class II · Moderate risk

Torco Racing Fuels Hand Sanitizer

CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.

Terminated cGMP deviation Torco Race Fuels D-0786-2022
Class II · Moderate risk

Hydroxocobalamin B12

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0080-30 D-0826-2022

Recalls by year